E. Yu. Lomakina

ORCID: 0000-0002-7703-8328
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Pancreatitis Pathology and Treatment
  • Autoimmune and Inflammatory Disorders
  • Gastrointestinal disorders and treatments
  • IgG4-Related and Inflammatory Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Eosinophilic Esophagitis
  • Neutropenia and Cancer Infections
  • Autoimmune and Inflammatory Disorders Research
  • Pancreatic and Hepatic Oncology Research
  • Diabetes and associated disorders
  • Genital Health and Disease
  • Celiac Disease Research and Management
  • Gastrointestinal motility and disorders
  • Diabetes Management and Research

Regional Clinical Research
2017-2025

Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky
2017-2025

.

10.33878/2073-7556-2023-22-3-10-49 article Koloproktologia 2023-08-28

AIM: to analyze publications and assess the current state of issue on comparative efficacy survival different classes lines biological therapy for inflammatory bowel diseases (IBD)MATERIALS AND METHODS: search was done in PUBMED, MEDLINE, EMBASE databases Cochrane Library from 2013 2024 using key words phrases “Inflammatory disease”, “ulcerative colitis”, “Crohn’s “biologics survival/persistence”, “comparative biologics lines”, “biologics”, “immunogenicity”. RESULTS: loss response over time...

10.33878/2073-7556-2025-24-1-103-114 article EN Koloproktologia 2025-02-20

The article indicates the specific niche and principles for choosing mesalazine formulations, selection of a dose treatment mild to moderate extensive (left-sided total) ulcerative colitis (UC). It doesn’t consider any approaches more severe UC or distal (proctitis). current concepts on use 5-aminosalicylic acid (5-ASA) formulations induce maintain remission in active are discussed. drug administration comparative analysis domestic international dosing recommendations provided. guidelines...

10.21518/ms2024-446 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-10-17

The aim of the study was to compare endosonographic signs pancreatic lesion in patients with inflammatory bowel diseases (IBD) and diagnosed chronic pancreatitis (CP). Materials methods. 62 IBD (39 ulcerative colitis (UC), 23 Crohn’s disease (CD)), 33 previously established CP without 42 were examined. All underwent examination pancreas an assessment parenchymal ductal criteria according Rosemont classification. Results. There no statistically significant difference when comparing changes UC...

10.31146/1682-8658-ecg-211-3-53-60 article EN cc-by Experimental and Clinical Gastroenterology 2023-07-25

Inflammatory bowel diseases (IBD) are commonly associated with extraintestinal manifestations, hematological disorders being the most special among them. In some cases, they dominate clinical picture masking intestinal manifestations of underlying disease. Aplastic anemia is an extremely rare IBD manifestation. There only two cases aplastic ulcerative colitis and non Crohn's disease reported in literature. Combination В₁₂-deficient more prevalent, but seen usually after than 20 cm ileus has...

10.18786/2072-0505-2017-45-5-429-438 article EN cc-by Almanac of Clinical Medicine 2017-01-01

Ulcerative colitis and Crohn’s disease are severe immune-mediated diseases. Extraintestinal manifestations of inflammatory bowel (IBD) significantly increase the burden to patient. The most common extraintestinal include erythema nodosum, ankylosing spondylitis, primary sclerosing cholangitis. Some depend on activity process in intestine can be reversed during treatment IBD, while others require specific therapy, since it does not degree inflammation intestine. Patients with IBD at increased...

10.21518/2079-701x-2020-15-121-126 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2020-10-22

The aim of the study was to compare endosonographic signs pancreatic lesion in patients with inflammatory bowel diseases (IBD) and diagnosed chronic pancreatitis (CP). Materials methods. 62 IBD (39 ulcerative colitis (UC), 23 Crohn’s disease (CD)), 33 previously established CP without 42 were examined. All underwent examination pancreas an assessment parenchymal ductal criteria according Rosemont classification. Results. There no statistically significant difference when comparing changes UC...

10.31146/1682-8658-ecg-213-5-73-80 article EN cc-by Experimental and Clinical Gastroenterology 2023-05-25

Crohn’s disease (CD) is a severe immune-mediated with segmental transmural inflammation and ulcers in gastrointestinal tract most often terminal ileum colon. The associated complications such as fistulas strictures that require aggressive treatment or surgery. CD remains the unresolved one of serious problems gastroenterology. Glucocorticosteroids (GCS) are essential options for many years but unfortunately frequency steroid resistance dependence constantly increasing. In cases refractory...

10.21518/2079-701x-2022-16-7-116-122 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2022-05-14
Coming Soon ...